The Zhitong Finance App learned that Kingsley Biotech (01548) rose by more than 5%. As of press release, it had risen 3.95% to HK$19.49, with a turnover of HK$287 million.

According to the news, Kingsley Biotech plans to hold a board meeting on August 15 to approve the interim results. The company previously announced that in the second quarter, LEGENDARY BIOLOGICAL CARVYKTI's sales reached US$657 million, up 49.4% year on year and 10% month on month. Sales for the first half of the year reached US$1,254 million, up 55.1% year over year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.